Revenue: As of FY2025 Q2, the actual value is USD 3.148 B.EPS: As of FY2025 Q2, the actual value is USD 0.13.EBIT: As of FY2025 Q2, the actual value is USD 9.779 M.<h3>Pharmacy Solutions Segment</h3><ul><li>Revenues: $2,790.1 million for Q2 2025, up from $2,114.5 million in Q2 2024, an increase of $675.6 million or 32.0%.</li><li>Cost of Goods: $2,556.4 million for Q2 2025, up from $1,931.8 million in Q2 2024, an increase of $624.6 million or 32.3%.</li><li>Gross Profit: $233.7 million for Q2 2025, up from $182.7 million in Q2 2024, an increase of $50.9 million or 27.9%.</li><li>Selling, General, and Administrative Expenses: $136.0 million for Q2 2025, up from $115.5 million in Q2 2024, an increase of $20.6 million or 17.8%.</li><li>Segment EBITDA: $124.7 million for Q2 2025, up from $94.5 million in Q2 2024, an increase of $30.2 million or 32.0%.</li></ul><h3>Provider Services Segment</h3><ul><li>Revenues: $357.6 million for Q2 2025, up from $323.8 million in Q2 2024, an increase of $33.8 million or 10.5%.</li><li>Cost of Services: $216.4 million for Q2 2025, up from $194.3 million in Q2 2024, an increase of $22.1 million or 11.4%.</li><li>Gross Profit: $141.2 million for Q2 2025, up from $129.4 million in Q2 2024, an increase of $11.7 million or 9.0%.</li><li>Selling, General, and Administrative Expenses: $91.9 million for Q2 2025, up from $84.7 million in Q2 2024, an increase of $7.1 million or 8.4%.</li><li>Segment EBITDA: $56.5 million for Q2 2025, up from $50.7 million in Q2 2024, an increase of $5.8 million or 11.4%.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Divestiture of Community Living Business: The company plans to divest its Community Living business for $835 million, expected to close in late 2025, to focus on senior and specialty populations.</li><li>Strategic Focus: The divestiture is expected to result in increased strategic focus, operational efficiencies, and greater clinical integration across the Provider Services segment.</li></ul>

BrightSpring Health Services - Unit | 10-Q: FY2025 Q2 Revenue: USD 3.148 B